MSB 2.08% 94.0¢ mesoblast limited

I’m concerned that they are trying not to achieve anything....

  1. 3,999 Posts.
    lightbulb Created with Sketch. 315
    I’m concerned that they are trying not to achieve anything. Having stats that can’t be compared to others. Their Covid trial is baffling and very very telling. They could skip ahead 10years on the governments purse and crush their competitors showing the error of their ways, complete with a manufacturing answer to theorised issues.

    Cyp has a advantage of seeing what others do and benefit by using learnings. If they actually want to succeed.

    as far as any manufacturing claim, they haven’t manufactured more than a few doses.

    SI said he looked at it, he obviously chose another way. The royalties I suggest would soak up any price difference

    someone described them as a marketing company, maybe

    anyway I think 3d is in the bag, something the loyal followers of CYP claimed didn’t exist. Lol

    I would caution any biotech investors, whatever timeline you think, double it and DYOR
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.